Ghost Tree Capital as of Dec. 31, 2014
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 56 positions in its portfolio as reported in the December 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 8.6 | $18M | 190k | 94.26 | |
Stryker Corporation (SYK) | 6.1 | $13M | 135k | 94.33 | |
ISIS Pharmaceuticals | 5.9 | $12M | 200k | 61.74 | |
Zimmer Holdings (ZBH) | 4.7 | $9.8M | 86k | 113.42 | |
Avalanche Biotechnologies In | 3.2 | $6.8M | 125k | 54.00 | |
Wright Medical | 3.0 | $6.3M | 235k | 26.87 | |
Puma Biotechnology (PBYI) | 2.7 | $5.7M | 30k | 189.27 | |
Flamel Technologies | 2.7 | $5.6M | 325k | 17.13 | |
Cepheid | 2.6 | $5.4M | 100k | 54.14 | |
Alnylam Pharmaceuticals (ALNY) | 2.6 | $5.3M | 55k | 97.00 | |
La Jolla Pharmaceuticl Com Par | 2.5 | $5.3M | 286k | 18.45 | |
DepoMed | 2.3 | $4.8M | 300k | 16.11 | |
Dyax | 2.2 | $4.6M | 325k | 14.06 | |
Actavis | 2.2 | $4.5M | 18k | 257.43 | |
Zeltiq Aesthetics | 2.1 | $4.5M | 160k | 27.91 | |
Nevro (NVRO) | 2.1 | $4.4M | 115k | 38.67 | |
Ptc Therapeutics I (PTCT) | 2.1 | $4.4M | 85k | 51.76 | |
NuVasive | 2.0 | $4.2M | 90k | 47.16 | |
Portola Pharmaceuticals | 2.0 | $4.2M | 150k | 28.32 | |
Insys Therapeutics | 2.0 | $4.2M | 100k | 42.16 | |
Horizon Pharma | 1.9 | $3.9M | 300k | 12.89 | |
Air Methods Corporation | 1.8 | $3.7M | 85k | 44.04 | |
BioMarin Pharmaceutical (BMRN) | 1.7 | $3.6M | 40k | 90.40 | |
Kite Pharma | 1.7 | $3.5M | 60k | 57.67 | |
Salix Pharmaceuticals | 1.6 | $3.4M | 30k | 114.93 | |
AMAG Pharmaceuticals | 1.6 | $3.4M | 80k | 42.62 | |
Advaxis | 1.6 | $3.4M | 423k | 8.01 | |
Universal Health Services (UHS) | 1.6 | $3.3M | 30k | 111.27 | |
Ophthotech | 1.4 | $2.9M | 65k | 44.88 | |
Quidel Corporation | 1.4 | $2.9M | 100k | 28.92 | |
Valeant Pharmaceuticals Int | 1.4 | $2.9M | 20k | 143.10 | |
Therapeuticsmd | 1.4 | $2.8M | 637k | 4.45 | |
Bluebird Bio (BLUE) | 1.3 | $2.8M | 30k | 91.73 | |
Amicus Therapeutics (FOLD) | 1.2 | $2.5M | 300k | 8.32 | |
Accuray Incorporated (ARAY) | 1.1 | $2.3M | 300k | 7.55 | |
Dbv Technologies S A (DBVT) | 1.0 | $2.2M | 80k | 27.12 | |
Intuitive Surgical (ISRG) | 1.0 | $2.1M | 4.0k | 529.00 | |
BioDelivery Sciences International | 1.0 | $2.1M | 175k | 12.02 | |
Ariad Pharmaceuticals | 1.0 | $2.1M | 300k | 6.87 | |
AtriCure (ATRC) | 1.0 | $2.0M | 100k | 19.96 | |
Achillion Pharmaceuticals | 0.9 | $1.8M | 150k | 12.25 | |
Immunogen Inc Cmn Stk cmn | 0.9 | $1.8M | 300k | 6.10 | |
Bellicum Pharma | 0.8 | $1.7M | 75k | 23.04 | |
Raptor Pharmaceutical | 0.8 | $1.6M | 150k | 10.52 | |
Merit Medical Systems (MMSI) | 0.6 | $1.3M | 75k | 17.33 | |
Tandem Diabetes Care | 0.6 | $1.3M | 100k | 12.70 | |
Nanostring Technologies (NSTGQ) | 0.6 | $1.3M | 90k | 13.93 | |
Smith & Nephew (SNN) | 0.5 | $1.1M | 30k | 36.73 | |
Auspex Pharmaceuticals | 0.5 | $1.1M | 20k | 52.50 | |
Wright Med Group Inc right 03/01/2019 | 0.4 | $884k | 185k | 4.78 | |
Biolase Technology | 0.4 | $789k | 300k | 2.63 | |
Ocera Therapeutics | 0.4 | $796k | 125k | 6.37 | |
Celladon | 0.4 | $781k | 40k | 19.52 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.4 | $743k | 250k | 2.97 | |
Assembly Biosciences | 0.2 | $511k | 65k | 7.86 | |
Globeimmune (GBIM) | 0.1 | $178k | 24k | 7.57 |